| DL-epinephrine; 4-(1-hydroxy-2-methylaminoethyl)benzene-1,2-diol; racepinephrine | |
| Links: | 📖 PubMed |
| MeSH: | Adrenergic Agents; Adrenergic alpha-Agonists; Anti-Asthmatic Agents; Autonomic Agents; Bronchodilator Agents; Neurotransmitter Agents; Vasoconstrictor Agents |
| Formula: | C9H13NO3; 183.21 g/mol |
| InChiKey: | UCTWMZQNUQWSLP-UHFFFAOYSA-N |
| SMILES: | CNCC(O)c1ccc(O)c(O)c1 |
| Toxicology (LD50): | 15.0 mg/Kg (mouse, sc); 17.0 mg/Kg(mouse, sc); 3.000 mg/Kg(rabbit, iv); 3.000 mg/Kg(rabbit, iv) |
| Melting point: | 212 °C |
| 4-(2-amino-1-hydroxyethyl)-2-methoxyphenol |
| 4-[(1R,2S)-2-amino-1-hydroxypropyl]benzene-1,2-diol |
| (-)-epinephrine |
| epinephrine |
| ethyl (E)-2-cyano-3-ethoxybut-2-enoate |
| ethyl 2-cyano-4-methyl-3-oxopentanoate |
| ethyl 2-cyano-3-oxohexanoate |
| ethyl 3-ethyl-5-methylisoxazole-4-carboxylate |
| 2-ethyl-3-hydroxy-1-(2-hydroxyethyl)pyridin-4-one |
| 3-hydroxy-2-(2,4-dihydroxyphenyl)propanamine |
| 3-hydroxy-2-(3,4-dihydroxyphenyl)propanamine |
| methyl 2-cyano-5-methyl-3-oxohexanoate |
| nordefrin |
| racepinephrine |
| 3,4,5-trimethoxyaniline |
